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SHORT TAKE
Mitochondrial mutations and aging: random drift is insufficient
to explain the accumulation of mitochondrial deletion mutants
in short-lived animals
Axel Kowald and Thomas B. L. Kirkwood
Centre for Integrated Systems Biology of Ageing and Nutrition, Institute for
Ageing and Health, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK
Summary
Mitochondrial DNA deletions accumulate over the life course in
post-mitotic cells of many species and may contribute to aging.
Often a single mutant expands clonally and finally replaces the
wild-type population of a whole cell. One proposal to explain the
driving force behind this accumulation states that random drift
alone, without any selection advantage, is sufficient to explain
the clonal accumulation of a single mutant. Existing mathematical
models show that such a process might indeed work for humans.
However, to be a general explanation for the clonal accumulation
of mtDNA mutants, it is important to know whether random drift
could also explain the accumulation process in short-lived species
like rodents. To clarify this issue, we modelled this process
mathematically and performed extensive computer simulations
to study how different mutation rates affect accumulation time
and the resulting degree of heteroplasmy. We show that random
drift works for lifespans of around 100 years, but for short-lived
animals, the resulting degree of heteroplasmy is incompatible
with experimental observations.
Key words: aging; mathematical model; mitochondrial muta-
tion.
Introduction
The mitochondrial theory of aging has for many years been among the
most popular, although recent questions have arisen concerning the
magnitude of its contribution. Point mutations and deletions of mtDNA
impair ATP production with negative consequences for all aspects of
cellular homoeostasis. Many studies have shown that mtDNA deletions
accumulate with age in various mammalian species such as rats,
monkeys and humans (Brierley et al., 1998; Khrapko et al., 1999; Cao
et al., 2001; Gokey et al., 2004; Herbst et al., 2007; McKiernan et al.,
2009). These single-cell studies have shown that the mitochondrial
population of a cell is often overtaken by a single deletion mutant type
via clonal expansion.
The mechanism behind the accumulation of defective mitochondria
is currently unknown. The ‘vicious cycle’ hypothesis suggests that,
because defective mitochondria generate more radicals, this increases
the production of mutants (Bandy & Davison, 1990; Arnheim &
Cortopassi, 1992). However, this also implies that one should see many
different mtDNA mutants in a single cell, quite the contrary of what has
been observed. An alternative idea is called ‘survival-of-the-slowest’ (de
Grey, 1997). This notes that the fate of a mutant depends on its rate of
degradation as well as growth and proposes that defective mitochon-
dria are degraded less frequently than wild-type. However, this
hypothesis has problems with mitochondrial dynamics, as fission and
fusion break the required link between genotype and phenotype
(Kowald & Kirkwood, 2011), and evidence shows that dysfunctional
mitochondria are preferentially degraded (Twig et al., 2008; Kim &
Lemasters, 2011), instead of being spared. It is also suggested that the
reduced genome size of the deletion mutant confers a selection
advantage (Wallace, 1992; Lee et al., 1998). However, the time
required for replication of mtDNA is only 1–2 h (Berk & Clayton,
1974; Clayton, 1982), while the half-life of mtDNA is in the order of 1–
3 weeks (Gross et al., 1969; Huemer et al., 1971; Korr et al., 1998).
Therefore, it is difficult to see how mtDNA replication could be a rate
limiting step for mitochondrial growth (de Grey, 1999; Elson et al.,
2001).
Finally, random drift might be sufficient to explain clonal expansion
(Chinnery & Samuels, 1999; Elson et al., 2001). Elson et al. (2001)
simulated a population of 1000 mtDNAs with a 10 day half-life and a
mutation probability between 106 and 104 per replication event. They
defined COX-negative cells as those that contain more than 60%
mutant mtDNA at the end of the simulation and showed that after
120 years, between 1 and 10% of COX-negative cells had a degree of
heteroplasmy compatible with experimental observations. However, can
such a process also work for short-lived animals like rodents, which show
a similar pattern of accumulation as in humans but on a greatly
accelerated timescale (Cao et al., 2001; Herbst et al., 2007)?
To address this question, we performed a stochastic simulation of
degradation and replication of 1000 mtDNA molecules inside a post-
mitotic cell. Each mtDNA has a half-life of 10 days, and after a molecule
has been degraded, one of the remaining molecules is randomly chosen
to replicate to maintain the population level. Mitochondrial deletions are
assumed to happen via slippage replication at perfect and imperfect
direct repeats (Shoffner et al., 1989; Guo et al., 2010b), and thus, each
replication leads, with a certain probability, Pmut, to a deletion. A mutant
has the same probabilities of degradation and replication as the wild-
type, so its numbers in the population follow a process of random drift.
The simulation is performed for a certain number of years during which
degradation and replication are calculated on an hourly basis. To get
statistical insight into the results, we performed 3000 repetitions of each
single simulation and calculated average values. The simulation program
was written in Java and the corresponding Eclipse project is available
from the authors.
To test the effect of different mutation rates, we performed
simulations over a time span of 120 years with mutation rates ranging
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from 106 to 104 (Fig. 1A). Like Elson et al. (2001), we define COX-
negative cells as those that contain more than 60% of mutant mtDNAs.
Our results are in excellent agreement with Fig. 1C of those authors,
except that we used more repetitions to get a better estimate of the
mean. This was especially necessary for a mutation rate of 106, which
resulted in a very low number of COX-negative cells. A mutation rate of
Pmut = 10
5 resulted in 2.7% of COXneg cells and a mutation rate of
Pmut = 10
4 gave 22.3% of COXneg cells at 120 years, a range
compatible with experimental observations in older people (Brierley
et al., 1998).
To investigate whether random drift can also account for the
accumulation of mtDNA mutants in shorter-lived animals, we calculated
the mutation rate needed to produce 5  0.5%, 10  0.5% and
15  0.5% COX-negative cells after a certain number of years. As
clonally expanded mtDNA mutants are found in rats (Cao et al., 2001;
Herbst et al., 2007), we started calculations for a lifespan as low as
3 years. As can be seen in Fig. 1B, it is possible to reach 5–15% of COX-
negative cells after just 3 years, but only with a mutation rate 200-fold
higher than what is required for a lifespan of 120 years (7.6 9 103 vs.
4 9 105).
An interesting further question concerns the degree of heteroplasmy
in the COX-negative cells. We therefore calculate the number of
different types of mtDNA molecules present at the end of the simulation.
Figure 1C shows the degree of heteroplasmy to increase dramatically
with decreasing lifespan. On average, more than 30 types of mtDNA
molecules are present in each COX-negative cell after 3 years of
simulation.
Could this heteroplasmy be observed experimentally? If there is one
dominant mutant, while all other types only exist in very small
numbers, it might be that standard PCR techniques only detect the
dominant form. To test this, we also calculated how frequent is the
most dominant mutant in COX-negative cells (Fig. 1D). For a 120 year
lifespan, the most frequent mutant is represented at well above 90%,
but this drops rapidly with decreasing lifespan and is below 20% for a
3 year lifespan.
A hallmark of mtDNA mutation accumulation in humans is the low
degree of heteroplasmy, that is, in the cells overtaken by a mutant
mtDNA, hardly any other mutant can be found. This is clearly also the
case in rats (Cao et al., 2001; Herbst et al., 2007). In mice, mitochondrial
deletions have also been found (Tanhauser & Laipis, 1995; Eimon et al.,
1996; Guo et al., 2010a), but no single-cell studies have yet been
reported, so that the degree of heteroplasmy is unknown. However,
even for a timeframe of 10–40 years, the number of mutants per cell is
too high to agree with observations. In rhesus monkeys, Gokey et al.
(2004) examined single muscle fibres in 29- and 39-year-old animals and
detected only a single, clonally expanded, deletion mutant per COX-
negative fibre. Yet, the simulations show that even for a 40-year lifespan
the most frequent mutant accounts for less than 80% of all mtDNAs in a
COX-negative cell. Thus, the heteroplasmy is readily detectable. For a
more complete overview, Table 1 summarizes the values displayed in
Fig. 1. As the measured values for mtDNA half-lives range from 1–
3 weeks and were quantified only for rodents but never for humans, we
also performed simulations with half-lives ranging from 5 to 20 days. In
general, an increasing half-life leads to a reduction in the number of
(A)
(C) (D)
(B)
Figure 1 (A) Time course of the
abundance of COX-negative cells over a
simulation period of 120 years for various
mutation rates. The time points are in
monthly intervals and are the mean of 3000
simulations for Pmut = 10
4 and 105, and
15000 simulations for Pmut = 10
6. COX-
negative cells are defined as those with
more than 60% mutant mtDNA.
(B) Mutation rates that are required to
result in 5, 10 and 15 of COX-negative cells
after a certain number of years. The data
points represent the mean of 3000
simulations for a lifespan of 3, 10, 40, 80
and 120 years. (C) Degree of heteroplasmy
given by the average number of different
mtDNAs in COX-negative cells after a
certain number of years. (D) Percentage of
most frequent mutant in COX-negative
cells after 3, 10, 40, 80 and 120 years of
simulation. Mutation rates were adjusted so
that 5, 10 and 15% of COX-negative cells
resulted after the indicated number of years
of simulation (see B).
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COX-negative cells, as mutation-prone replications occur less frequently
(results not shown). The degree of heteroplasmy changes very little.
Therefore, the specific value of the mtDNA half-life does not affect the
main message of the simulations.
What do our results mean for understanding the accumulation of
mitochondrial deletion mutants? In principle, random drift is a viable
explanation for the accumulation pattern in humans and other long-lived
species, but it is not a general explanation for the vast majority of
mammalian species (nor has its contribution been investigated in
very short-lived invertebrates). As mentioned in the introduction, neither
the vicious cycle nor survival-of-the-slowest-hypotheses are compatible
with experimental findings. This leaves the idea that deletion mutants
might have a selection advantage because they have a shorter replication
time. But this idea has also been criticized and a simulation study that we
recently performed (Kowald, A., unpublished data) confirms that the
large discrepancy between the half-life and replication time of mtDNA
molecules results in unrealistic predictions regarding the time required
for the accumulation process.
Thus, intriguingly, there currently exists no idea that satisfactorily
explains the observed clonal expansion of mtDNA deletion mutants in
short-lived as well as long-lived animals, confirming the importance of
careful quantitative study of the mitochondrial aging hypothesis. But
what properties are required for this unknown mechanism? To explain
the wide inter-species range of accumulation times displayed by
deletion mutants at the tissue level, two scenarios are possible. One is
that the hypothetical mechanism controls the speed of the accumu-
lation process itself at the single-cell level. If the rate of accumulation
of a mutant inside a cell is species specific, being faster for short-lived
than long-lived species, then the accumulation rate in a tissue will
show the same time dependence. An alternative is that the accumu-
lation process in all mammalian cells is similar and very fast (i.e. shorter
than a rodent lifespan) but that the initiation of the accumulation is
triggered in individual cells at different time points, and that it is the
likelihood of such initiation that differs between species. In the second
scenario, although individual cells experience rapid accumulation, the
statistical variability among the cells in time point when the accumu-
lation begins will result in the same continuous pattern of tissue
accumulation as in the first. The challenge is to identify which aspects
of mitochondrial biochemistry can provide the mechanistic basis for
these scenarios.
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